A thoughtful consultation can help determine whether peptide therapy belongs in the conversation, whether another medical evaluation should come first, and how to monitor progress if a peptide-related strategy is considered
Remember that successful diabetes management is a partnership between you and your healthcare team, and open communication about dosing challenges is an important part of that collaborative relationship
Grouping and read-across approaches for risk assessment of nanomaterials
Most patients accept this trade-off given the significant waist contour improvement the procedure delivers
Obesity, diabetes, and gut microbiota: The hygiene hypothesis expanded
About Educational Initiatives Given the critical connection between diabetes and cardiovascular disease, Boehringer Ingelheim and Eli Lilly and Company are committed to providing a wide range of diabetes therapies along with programs and support to raise awareness, understanding and action toward reducing the impact of cardiovascular disease in people with type 2 diabetes